FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:935-941 March 1, 2007 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the author's clinical recommendations.

A 73-year-old man with stable coronary artery disease, hypertension, and chronic renal insufficiency presents with recurrent atrial fibrillation at 80 to 90 beats per minute. His symptoms include shortness of breath and fatigue. He has had atrial fibrillation twice . . . [Full Text of this Article]

The Clinical Problem

Pathophysiology and Effect of Therapy

Clinical Evidence

Clinical Use

Adverse Effects

Areas of Uncertainty

Guidelines

Recommendations

Source Information

From the Division of Cardiology, Beth Israel Deaconess Medical Center, Boston.

Address reprint requests to Dr. Zimetbaum at Beth Israel Deaconess Medical Center, 185 Pilgrim Rd., Boston, MA 02215, or at pzimetba@bidmc.harvard.edu.

Related Letters:

Amiodarone for Atrial Fibrillation
Rehman H. u., Kurnik D., Loebstein R., Olchovsky D., Coceani M., Skolnik N., Armon C., Zimetbaum P.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:2424-2426, Jun 7, 2007. Correspondence

This article has been cited by other articles:

• Piccini, J. P., Hasselblad, V., Peterson, E. D., Washam, J. B., Califf, R. M., Kong, D. F. (2009). Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.. J Am Coll Cardiol 54: 1089-1095 [Abstract] [Full Text]  
• Tisdale, J. E., Wroblewski, H. A., Wall, D. S., Rieger, K. M., Hammoud, Z. T., Young, J. V., Kesler, K. A. (2009). A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.. Ann. Thorac. Surg. 88: 886-893 [Abstract] [Full Text]  
• Orr, C. F., Ahlskog, J. E. (2009). Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity. Arch Neurol 66: 865-869 [Abstract] [Full Text]  
• Forleo, G. B., Tondo, C. (2009). Atrial fibrillation: cure or treat?. Ther Adv Cardiovasc Dis 3: 187-196 [Abstract]  
• Willis, M. S., Lugo, A. M. (2009). Amiodarone-induced neurotoxicity. Am J Health Syst Pharm 66: 567-569 [Abstract] [Full Text]  
• Ahmed, S., Rienstra, M., Crijns, H. J. G. M., Links, T. P., Wiesfeld, A. C. P., Hillege, H. L., Bosker, H. A., Lok, D. J. A., Van Veldhuisen, D. J., Van Gelder, I. C., for the CONVERT Investigators, (2008). Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation: A Randomized Trial. JAMA 300: 1784-1792 [Abstract] [Full Text]  
• Hindle, J. V., Ibrahim, A., Ramaraj, R. (2008). Ataxia caused by amiodarone in older people. Age Ageing 37: 347-348 [Abstract] [Full Text]  
• Vassallo, P., Trohman, R. G. (2007). Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications. JAMA 298: 1312-1322 [Abstract] [Full Text]  
• Ezekowitz, M. D. (2007). Maintaining Sinus Rhythm -- Making Treatment Better Than the Disease. NEJM 357: 1039-1041 [Full Text]  
• Rehman, H. u., Kurnik, D., Loebstein, R., Olchovsky, D., Coceani, M., Skolnik, N., Armon, C., Zimetbaum, P. (2007). Amiodarone for Atrial Fibrillation. NEJM 356: 2424-2426 [Full Text]